Form 4: Chubb Ltd President & COO John W. Keogh Executes Stock Option and Sells Shares
SEC Form 4 Filing
John W. Keogh, President & COO of Chubb Ltd, exercised stock options and sold shares on May 8, 2024, according to a Form 4 filing with the SEC.
Summary
- On May 8, 2024, John W. Keogh, the President & COO of Chubb Ltd, exercised options to acquire 34,103 common shares at a price of $114.78.
- Following the exercise, Keogh sold 33,232 shares at a weighted average price of $251.98, with prices ranging from $251.89 to $252.20 per share.
- An additional 1,475 shares were sold at a weighted average price of $251.95, with prices ranging from $251.93 to $251.97 per share.
- Shares were also attested to cover the exercise price and withholding taxes.
- After these transactions, Keogh directly owns 284,136 common shares and indirectly owns 29,380.01 shares through daughter's trusts.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of insider trading activity. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the buying and selling activities of company executives. It's common for executives to exercise stock options and sell a portion of the acquired shares for personal financial management.
Comparison to Industry Standards
- Monitoring insider transactions is a standard practice in corporate governance.
- Comparing Keogh's transactions to those of executives at similar insurance companies like AIG, MetLife, or Prudential could provide context on whether these actions are typical or unusual.
- The timing and size of the transactions relative to Chubb's stock performance and industry trends are important factors to consider.
Stakeholder Impact
- The transactions could have a minor impact on shareholders due to the change in ownership, but the effect is likely minimal given the overall size of the company.
- There is no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/26/2016 | 1/3 of options vested |
| 02/26/2017 | 1/3 of options vested |
| 02/26/2018 | 1/3 of options vested |
| 05/08/2024 | Earliest transaction date, option exercise and share sales |
| 05/09/2024 | Date of signature for the Form 4 filing |
| 02/26/2025 | Expiration date of options exercised |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.